Creatine prevents ouabain-induced manic-like behavior by modulating GSK-3β via PI3K/AKT/mTOR pathway
Pharmacology Biochemistry and Behavior · 2025-12 · 257 · 174115
DOI: 10.1016/j.pbb.2025.174115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2025-12. Verfasst von Adson Souza-Pereira und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Graduate Program, Federal University of Pampa, Uruguaiana, RS, Brazil. Hauptthemen laut MEDLINE: Glycogen Synthase Kinase 3 beta, Ouabain, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, National Council for Scientific and Technological Development.
Abstract (Originalsprache)
Bipolar disorder is a chronic psychiatric condition marked by alternating episodes of mania and depression. Current pharmacological treatments show limited efficacy and are often associated with incomplete remission. Creatine, a compound involved in energy buffering, mitochondrial function, and neuromodulation, has demonstrated neuroprotective and potential mood-stabilizing properties. However, the underlying mechanisms remain poorly understood. This study evaluated the effects of acute oral creatine administration (300 mg/kg) on behavioral and molecular changes in a validated rat model of mania induced by intracerebroventricular ouabain (10-3 M), a Na+/K+-ATPase inhibitor. Behavioral alterations were assessed using the open field test, and hippocampal samples were analyzed for enzyme activity and key signaling proteins. Creatine significantly attenuated ouabain-induced hyperactivity and increased latency to symptom onset. At the molecular level, creatine preserved Na+/K+-ATPase activity and reduced phosphorylation of its α-subunit at a regulatory site. Additionally, creatine enhanced activation of the PI3K/AKT/mTOR/p70S6K pathway and prevented the ouabain-induced activation of GSK-3β, a kinase involved in mood regulation. Notably, rapamycin, an mTOR inhibitor, reversed the behavioral effects of creatine, suggesting a mechanistic role for this pathway. These findings demonstrate that acute creatine administration confers both behavioral and neurochemical protection in a mania model and supports its potential as an adjunctive therapeutic strategy for individuals with bipolar disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry Graduate Program, Federal University of Pampa, Uruguaiana, RS, Brazil.
- Department of Methods and Sportive Techniques, Federal University of Santa Maria, Santa Maria, RS, Brazil.
- Biochemistry Graduate Program, Federal University of Pampa, Uruguaiana, RS, Brazil. Electronic address: leonardorambo@unipampa.edu.br.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- National Council for Scientific and Technological Development
Zitieren
APA
Souza-Pereira, A., da Silva Guerra, J. M., Nieswald, B. H., Maidana, L. M., Correa, A. B., Godinho, D. B., Royes, L. F. F., & Rambo, L. M. (2025). Creatine prevents ouabain-induced manic-like behavior by modulating GSK-3β via PI3K/AKT/mTOR pathway. Pharmacology Biochemistry and Behavior, 257, 174115. https://doi.org/10.1016/j.pbb.2025.174115
Vancouver
Souza-Pereira A, da Silva Guerra JM, Nieswald BH, Maidana LM, Correa AB, Godinho DB, et al. Creatine prevents ouabain-induced manic-like behavior by modulating GSK-3β via PI3K/AKT/mTOR pathway. Pharmacology Biochemistry and Behavior. 2025;257:174115. doi:10.1016/j.pbb.2025.174115
BibTeX
@article{SouzaPereira2025,
author = {Souza-Pereira, Adson and da Silva Guerra, Jozyê Milena and Nieswald, Bruno Henrique and Maidana, Luan Machado and Correa, Amistron Benites and Godinho, Douglas Buchmann and Royes, Luiz Fernando Freire and Rambo, Leonardo Magno},
title = {Creatine prevents ouabain-induced manic-like behavior by modulating GSK-3β via PI3K/AKT/mTOR pathway},
journal = {Pharmacology Biochemistry and Behavior},
year = {2025},
volume = {257},
pages = {174115},
doi = {10.1016/j.pbb.2025.174115}
}
EUVIMED